Jaime Frias - Mar 8, 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Legal Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Jaime Frias
Stock symbol
TMCI
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 07:21 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +7.88K +18.41% $0.00 50.7K Mar 8, 2022 Direct F1, F2, F3
holding TMCI Common Stock 226K Mar 8, 2022 Pacific Premiere Trust FBO Jaime A. Frias, IRA F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +60.8K $0.00 60.8K Mar 8, 2022 Common Stock 60.8K $19.15 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 7,875 RSUs.
F3 On April 29, 2021, a Form 4 was filed, which inadvertently reported that, following a stock split related to the Issuer's IPO, the Reporting Person directly owned 42,786 shares of Common Stock. Applying the correct stock split ratio, which rounded down fractional shares, the Reporting Person indirectly owned 42,784 shares. This correction has been reflected in this filing.
F4 On April 29, 2021, a Form 4 was filed which inadvertently reported that, following a stock split related to the Issuer's IPO, the Reporting Person indirectly owned 225,551 shares of Common Stock. Applying the correct stock split ratio, which rounded down fractional shares, the Reporting Person indirectly owned 225,549 shares. This correction has been reflected in this filing.
F5 The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.